VVOS
Vivos Therapeutics, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$0.19
+6.76%Margins
Gross margin
59.7%
EBITDA margin
-111.2%
EBIT margin
-107.9%
Net margin
-122.4%
FCF margin
-85.8%
670.7%
Return on equity
-106.0%
Return on assets
-271.0%
Return on invested capital
0.85x
Asset turnover
-$17.1M
Cash from operations
$0.09
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026